Employers › Adma Biologics
Recordkeeping fees per participant · Adma Biologics, Inc. 401(k) Plan · plan year 2024
$316.63
Higher than 96% of the 14,075 plans $10 to 50M that report it.
= $142,802 / 451
Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20251015144104NAL0010127026002, received 2025-10-15
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251015144104NAL0010127026002, received 2025-10-15
Percentiles compare this plan with the Schedule H plans $10 to 50M in assets of the same plan year, excluding final filings; shown only where at least 50 comparable plans report the figure. Plan year 2024-01-01 to 2024-12-31, filing received 2025-10-15.
Administrative expenses excluding investment management, per participant
$316.63
Higher than 88% of the 24,371 plans $10 to 50M that report it.
= $142,802 / 451
derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20251015144104NAL0010127026002, received 2025-10-15
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251015144104NAL0010127026002, received 2025-10-15
Administrative expenses per participant
$316.63
Higher than 74% of the 25,098 plans $10 to 50M that report it.
= $142,802 / 451
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251015144104NAL0010127026002, received 2025-10-15
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251015144104NAL0010127026002, received 2025-10-15
Administrative expenses as a share of assets
0.438%
Higher than 75% of the 25,132 plans $10 to 50M that report it.
= $142,802 / $32,568,353
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251015144104NAL0010127026002, received 2025-10-15
assets_eoy: Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20251015144104NAL0010127026002, received 2025-10-15
Employer contributions per participant
$3,304
Higher than 77% of the 24,050 plans $10 to 50M that report it.
= $1,490,170 / 451
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251015144104NAL0010127026002, received 2025-10-15
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251015144104NAL0010127026002, received 2025-10-15
Employer share of total contributions
27.7%
Higher than 49% of the 24,084 plans $10 to 50M that report it.
= $1,490,170 / $5,381,933
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251015144104NAL0010127026002, received 2025-10-15
total_contrib: Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20251015144104NAL0010127026002, received 2025-10-15
Plan terms are described in Adma Biologics, Inc.'s SEC filings: Form 10-K filed 2026-02-25. No term could be quoted from them with the required precision.
2E profit-sharing · 2F ERISA 404(c) plan · 2G fully participant-directed · 2J 401(k) feature · 2K 401(m) arrangement · 2T default investment (QDIA) · 3D IRS pre-approved plan · Form 5500, line 8a; TYPE_PENSION_BNFT_CODE pos 81; filing 20251015144104NAL0010127026002, received 2025-10-15
| Field | Value | Source |
|---|---|---|
| Plan sponsor | ADMA BIOLOGICS, INC. | Form 5500, Part II line 2a; SPONSOR_DFE_NAME pos 19; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Plan name | ADMA BIOLOGICS, INC. 401(K) PLAN | Form 5500, line 1a; PLAN_NAME pos 16; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Sponsor EIN / plan number | 56-2590442 / 001 | Form 5500, line 2b; SPONS_DFE_EIN pos 44; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Plan type | single-employer | Form 5500, Part I line A; TYPE_PLAN_ENTITY_CD pos 4; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Sponsor location | BOCA RATON, FL | Form 5500, line 2a; SPONS_DFE_MAIL_US_STATE pos 25; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Industry (business code) | 325410, Manufacturing | Form 5500, line 2d; BUSINESS_CODE pos 46; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Plan year | 2024-01-01 to 2024-12-31 | Form 5500, Part I plan year; FORM_PLAN_YEAR_BEGIN_DATE pos 2; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Filing received | 2025-10-15 | Form 5500, EFAST2 receipt date; DATE_RECEIVED pos 102; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Final filing | no | Form 5500, Part I line B; FINAL_FILING_IND pos 8; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Amended filing | no | Form 5500, Part I line B; AMENDED_IND pos 7; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Participants, beginning of year | 722 | Form 5500, line 5; TOT_PARTCP_BOY_CNT pos 71; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Active participants | 653 | Form 5500, line 6a(2); TOT_ACTIVE_PARTCP_CNT pos 72; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Participants, end of year | 752 | Form 5500, line 6f; TOT_ACT_RTD_SEP_BENEF_CNT pos 77; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Participants with an account balance | 451 | Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Total assets, beginning of year | $27,095,213 | Schedule H, Part I line 1f col (a); TOT_ASSETS_BOY_AMT pos 30; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Total assets, end of year | $32,568,353 | Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Net assets, end of year | $32,568,353 | Schedule H, line 1l col (b); NET_ASSETS_EOY_AMT pos 67; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Total income | $9,397,367 | Schedule H, Part II line 2d; TOT_INCOME_AMT pos 97; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Net income | $5,473,140 | Schedule H, line 2k; NET_INCOME_AMT pos 111; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Employer contributions | $1,490,170 | Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Participant contributions | $2,797,417 | Schedule H, line 2a(1)(B); PARTICIPANT_CONTRIB_AMT pos 69; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Other contributions (incl. rollovers) | $1,094,346 | Schedule H, line 2a(1)(C); OTH_CONTRIB_RCVD_AMT pos 70; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Total contributions | $5,381,933 | Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Benefit payments | $3,781,425 | Schedule H, line 2e(4); TOT_DISTRIB_BNFT_AMT pos 101; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Total expenses (incl. benefit payments) | $3,924,227 | Schedule H, line 2j; TOT_EXPENSES_AMT pos 110; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Total administrative expenses | $142,802 | Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Recordkeeping fees | $142,802 | Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Administrative expenses excluding investment management | $142,802 | derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Held in mutual funds | $30,309,290 | Schedule H, line 1c(13) col (b); INT_REG_INVST_CO_EOY_AMT pos 55; filing 20251015144104NAL0010127026002, received 2025-10-15 |
| Independent auditor | SOCORRO PARTNERS CPAS & ADVISORSLLC | Schedule H, Part III line 3a; ACCOUNTANT_FIRM_NAME pos 116; filing 20251015144104NAL0010127026002, received 2025-10-15 |
Position = column in the DOL layout for form year 2024. Filing 20251015144104NAL0010127026002, received 2025-10-15.
| Provider | Relationship | Service codes | Direct compensation | Indirect |
|---|---|---|---|---|
| TRANSAMERICA RETIREMENT SOLUTIONSrecordkeeper | RECORDKEEPER | 15 Recordkeeping and information management; 37 Participant loan processing; 52 Investment management fees paid indirectly by plan; 62 Float revenue; 64 Recordkeeping fees; 67 Other insurance wrap fees | $142,802 | yes |
| CADARET, GRANT & CO., INC. | BROKER | 22 Insurance agents and brokers; 23 Insurance services; 53 Insurance brokerage commissions and fees | $0 | yes |
Schedule C Part I line 2: name (a), service codes (b), relationship (c), direct compensation paid by the plan (d), indirect compensation received (e). Filing 20251015144104NAL0010127026002, received 2025-10-15.
| Figure | 2023 | 2024 | Change |
|---|---|---|---|
| Total assets | $27,095,213 | $32,568,353 | 20.2% |
| Participants with a balance | 424 | 451 | 6.4% |
| Administrative expenses | $133,944 | $142,802 | 6.6% |
| Recordkeeping fees per participant | $315.91 | $316.63 | 0.2% |
| Employer contributions | $1,344,254 | $1,490,170 | 10.9% |
Prior filing 20241008123829NAL0017540801003, received 2024-10-08; the plan years are contiguous.
Sponsor name as filed: ADMA BIOLOGICS, INC.; SEC registrant: ADMA BIOLOGICS, INC. (CIK 1368514, matched by EIN; display name from the Form 10-K cover).